a study from researchers at the University of Pittsburgh engineers artificial microparticles that trick the recipient's immune system into accepting donor transplanted tissue as its own. The team states their synthetic particle biomimics the ploy cancer cells use to evade an immune attack, to propagate and spread.

healthinnovations, immunology, opensource, synthetic biology

Synthetic cell biomimics cancer to avoid transplant rejection.

For people dealing with the life-changing and often devastating aftermath of disfiguring injuries or the loss of limbs, minimal reconstruction using the patients’ own tissues may not be a sufficient remedy for some patients. Face and limb transplantation, known as Vascularized Composite Allotransplantation (VCA), requires multiple types of tissue to successfully function, these may include skin, muscle, nerves, and blood vessels. As with organ transplantation, … Continue reading Synthetic cell biomimics cancer to avoid transplant rejection.